Navigation Links
OpenQ Announces the Release of openIIS 2.5
Date:5/27/2010

Latest Version of openQ’s software for Investigator Initiated Studies Offers Expanded Features for Compliance and Effectiveness.

Charlottesville, VA, San Francisco, CA, New York, NY and Paris, France (PRWEB) May 27, 2010 -- Building on their previous releases, openQ has released an expanded offering for managing Investigator Initiated Studies/ Trials (IIS/IIT). openIIS 2.5 provides a broad set of tools to manage the complete IIS lifecycle, from study submission and internal review, to study closeout.

openIIS is designed from the ground up to support regulatory compliance in an era of increasing federal scrutiny. Transparent customer business processes, through clearly documented and extensive audit trails, provide customers with complete access to decision criteria - including who reviewed the application, when they reviewed it, and why they made their decision. Expanded reporting functionally provides insight into studies, supporting critical areas such as financial controls.

While openIIS comes pre-configured with best practices gleaned from openQ’s industry experience, this doesn’t mean that customers are forced into a constrictive environment. The system also provides a configurable workflow engine to give customers the flexibility to configure the software to match their standard operating procedures.

“Despite its broad feature set and business process flexibility, we wanted to make openIIS easy to use,” said Matt Prentis, Director of Product Management at openQ. “Leveraging easily accessible portals for external investigators and internal users, along with submission wizards to guide investigators as they navigate the submission process help provide a smooth user experience. Additionally, key functionality to support multi-company sponsored grants simplifies even the more complex management tasks.”

openIIS is part of a broad portfolio of software and data offerings that openQ provides to Life Sciences companies. openQ provides solutions in KOL Management, Medical Affairs Programs, Grant Funding & Study Management, and Speaker Programs.

About openQ:
Based in Charlottesville, Virginia, openQ helps Life Sciences companies manage compliant business processes in their Marketing and Medical Affairs organizations. openQ’s solutions currently support compliance initiatives at 8 of the Top 10 Pharmaceutical and 3 of the Top 5 Medical Device Companies. For more information, visit openq.com.

###

Read the full story at http://www.prweb.com/releases/openQ/openIIS_Release/prweb4057984.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Direct Selling Reps' Association Announces 2010 Certificate Of Excellence Recipients
2. Dorland Health Announces People Awards Honoring Excellence & Dedication Among Healthcare Professionals - Call For Entries
3. 2 BigHearts Board Announces Addition to Board of Directors: Michael Unetich
4. George Carter of Carter's Plumbing & Rooter Announces the Launch of His New Website, CartersPlumbingRedondoBeach.com
5. The Hoppen Group Announces Partnership with SnapComms Tools
6. Jolly Announces the Release of ID Flow 5.0
7. Golden Age Resources, Inc. Announces Strategic Alliance with JK Development of Palm Beach County LLC in an Attempt to Stop the Oil Leak in the Gulf
8. Hospital Focus 5 Announces Contract with Connecticut Hospital to Improve Quality, Productivity and Cost-Effectiveness
9. Nature's Aide Vitamins, Inc. Announces a New Science Driven Osteo-Guard Vitamin Formula Designed to Quickly and Safely Halt Bone Deterioration
10. Massage Envy Announces Franchisee of the Year
11. PHD Virtual Technologies Announces Citrix Investment
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
OpenQ Announces the Release of openIIS 2.5 
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... Yisrayl Hawkins, ... focuses on Bible Prophecy concerning this present generation. Yisrayl makes an astounding statement ... current generation. He explains that the Bible details the current times so plainly ...
(Date:2/24/2017)... ... February 24, 2017 , ... Congratulations to Head Over Heels’ ... February 12th. Ms. Esparza qualified into this prestigious status after winning the ... Las Vegas, Nevada. Frida is one of approximately 25 gymnasts in the nation ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through ... return to the La Gorce Country Club in Miami Beach to host its ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rosica Communications, a ... content marketing, social media management, corporate communications, SEO and cause marketing, is opening ... in nearby New Hampshire, Massachusetts and Canada, Rosica will focus on expanding its ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... and uncertainty in clinical trials, today announced that Premier Research, a leading clinical ... solution. , Clinical trials are becoming increasingly complex, due in part to an ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... -- ITL Limited, ( ASX: ITD ), an innovative diversified healthcare ... ended 31 December 2016 compared with the previous corresponding period. A ... here . Highlights ... Earnings per share of 2.2 cents (Dec 2015: 1.2 ... $15.7m; up 11%) Profit before tax of $2.12m ...
(Date:2/23/2017)... Research and Markets has announced the addition of the "Oesophageal ... their offering. ... The latest research Oesophageal Cancer Drugs Price Analysis and Strategies - ... Cancer market. The research answers the following questions: ... Oesophageal Cancer and their clinical attributes? How are they positioned in ...
(Date:2/23/2017)... VALLEY COTTAGE, New York , February 23, 2017 ... to health implications arising from increasing caseload for varicose ... cases recorded across the globe are prompting the adoption ... A latest study on global endovenous laser therapy ... growing attention towards aftereffects of lifestyle choices and consequences ...
Breaking Medicine Technology: